We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Development of Monoclonal Antibodies in China: Overview and Prospects.
- Authors
Zhang, Mao-Yu; Lu, Jin-Jian; Wang, Liang; Gao, Zi-Chao; Hu, Hao; Ung, Carolina Oi Lam; Wang, Yi-Tao
- Abstract
Monoclonal antibodies (mAbs) have become increasingly important as human therapeutic agents. Yet, current research concentrates on technology itself and pays attention to developed countries. This paper aims to provide a comprehensive review of mAbs development in China through systematic analysis of drug registry, patent applications, clinical trials, academic publication, and ongoing R&D projects. The trends in therapeutic areas and industrialization process are also highlighted. Development and research trends of mAbs are analyzed to provide a future perspective of mAbs as therapeutic agents in China.
- Subjects
CHINA; UNITED States; CLINICAL drug trials; ECONOMICS; MONOCLONAL antibodies; TECHNOLOGY; TUMOR necrosis factors; VASCULAR endothelial growth factors
- Publication
BioMed Research International, 2015, Vol 2015, p1
- ISSN
2314-6133
- Publication type
Article
- DOI
10.1155/2015/168935